Memory enhancement: The search for mechanism-based drugs

Nature Neuroscience

Volumn 5, Issue 11s, 2002, Pages 1035-1038

  Lynch, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

DRUG MECHANISM; HUMAN; MEMBRANE DEPOLARIZATION; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SYNAPTIC TRANSMISSION; TARGET CELL;

ANIMALS; BIOMEDICAL RESEARCH; BRAIN; DRUG DESIGN; DRUG INDUSTRY; HUMANS; LONG-TERM POTENTIATION; MEMORY; MEMORY DISORDERS; NEUROSCIENCES; RECEPTORS, AMPA;

EID: 0036828992     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn935     Document Type: Review

References (34)

1. Bliss, T. V. P. & Lomo, T. Long-lasting potentiation of synaptic transmission in the dentate area of the anesthetized rabbit following stimulation of the perforant path. J. Physiol. (Lond.) 232, 334-356 (1973).
2. Martin, S. J., Grimwood, P. D. & Morris, R. G. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649-711 (2000).
3. Duncan, C.P. The retroactive effect of electroshock on learning. J. Comp. Physiol. Psychol. 42, 32-44 (1949).
4. Lynch, G. & Baudry, M. The biochemistry of memory: a new and specific hypothesis. Science 224, 1057-1063 (1984).
5. Malinow, R. & Malenka, R. C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25, 103-126 (2002).
6. Lee, H. K., Barbarosie, M., Kameyama, K., Bear, M. F. & Huganir, R. L. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405, 955-959 (2000).
7. Barrionuevo, G., Schottler, F. & Lynch, G. The effects of repetitive low frequency stimulation on control and “potentiated” synaptic responses in the hippocampus. Life Sci. 27, 2385-2391 (1980).
8. Dityatev, A., Dityateva, G. & Schachner, M. Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM. Neuron 26, 207-217 (2000).
9. Kramar, E. A., Bernard, J. A., Gall, C. M. & Lynch, G. Alpha3 integrin receptors contribute to the consolidation of long-term potentiation. Neuroscience 110, 29-39 (2002).
10. Nguyen, P. V. & Kandel, E. R. A macromolecular synthesis-dependent late phase of long-term potentiation requiring cAMP in the medial perforant pathway of rat hippocampal slices. J. Neurosci. 16, 3189-3198 (1996).
11. Frey, U. & Morris, R. G. Synaptic tagging and long-term potentiation. Nature 385, 533-536 (1997).
12. Staubli, U., Rogers, G. & Lynch, G. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. USA 91, 777-781 (1994).
13. Arai, A., Kessler, M., Rogers, G. & Lynch, G. Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus. J. Pharmacol. Exp. Ther. 278, 627-638 (1996).
14. Hampson, R., Rogers, G., Lynch, G. & Deadwyler, S. Facilitative effects of the ampakine CX516 on short term memory in rats: correlations with hippocampal unit activity. J. Neurosci. 18, 2748-2763 (1998).
15. Pirotte, B. et al. 4H-1, 2, 4-Pyridothiadiazine 1, 1-dioxides and 2, 3-dihydro-4H-1, 2, 4-pyridothiadiazine 1, 1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships. J. Med. Chem. 41, 2946-2959 (1998).
16. Baumbarger, P. J., Muhlhauser, M., Zhai, J., Yang, C. R. & Nisenbaum, E. S. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator. J. Pharmacol. Exp. Ther. 298, 86-102 (2001).
17. Gates, M., Ogden, A. & Bleakman, D. Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro. Neuropharmacology 40, 984-991 (2001).
18. Arai, A. C., Kessler, M., Rogers, G. & Lynch, G. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol. Pharmacol. 58, 802-813 (2000).
19. Arai, A. & Lynch, G. AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices. Brain Res. 799, 235-242 (1998).
20. Dash, P. K., Hochner, B. & Kandel, E. R. Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation. Nature 345, 718-721 (1990).
21. Barco, A., Alarcon, J. M. & Kandel, E. R. Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 108, 689-703 (2002).
22. Yin, J. C. et al. Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila. Cell 79, 49-58 (1994).
23. Bourtchuladze, R. et al. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79, 59-68 (1994).
24. Kida, S. et al. CREB required for the stability of new and reactivated fear memories. Nat. Neurosci. 5, 348-355 (2002).
25. Yin, J. C., Del Vecchio, M., Zhou, H. & Tully, T. CREB as a memory modulator: induced expression of a dCREB2 activator isoform enhances long-term memory in Drosophila. Cell 81, 107-115 (1995).
26. Josselyn, S. A. et al. Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J. Neurosci. 21, 2404-2412 (2001).
27. Nagakura, A., Niimura, M. & Takeo, S. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Br. J. Pharmacol. 135, 1783-1793 (2002).
28. Zhu, J., Mix, E. & Winblad, B. The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev. 7, 387-398 (2001).
29. Lauterborn, J. C., Lynch, G., Vanderklish, P., Arai, A. & Gall, C. M. Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J. Neurosci. 20, 8-21 (2000).
30. Mackowiak, M., O’Neill, M. J., Hicks, C. A., Bleakman, D. & Skolnick, P. An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study. Neuropharmacology (in press).
31. Ingvar, M. et al. Enhancement by an ampakine of memory encoding in humans. Exp. Neurol. 146, 553-559 (1997).
32. Lynch, G. et al. Evidence that a positive modulator of AMPA-type glutamate receptors affects delayed recall in aged humans. Exp. Neurol. 145, 89-92 (1997).
33. Gainetdinov, R. R., Mohn, A. R., Bohn, L. M. & Caron, M. G. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc. Natl. Acad. Sci. USA 98, 11047-11054 (2001).
34. Goff, D. C. et al. A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. J. Clin. Psychopharmacol. 21, 484-487 (2001).